Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Thromb Res ; 224: 38-45, 2023 04.
Artículo en Inglés | MEDLINE | ID: mdl-36827954

RESUMEN

BACKGROUND: The ISTH-SSC guidelines for lupus anticoagulant (LA) testing recommend using in-house determined cut-off values, pooled normal plasma (PNP) for ratio normalization, and a ratio for the mixing test interpretation. They strongly support the mixing step role in the diagnostic process. OBJECTIVES: To investigate and compare the LA testing results and interpretations obtained following the ISTH-SSC guidelines or the available alternatives. PATIENTS/METHODS: Blood samples for LA testing from 462 consecutive patients were evaluated for screening, mixing and confirmatory tests. The analysis focused on the interpretation differences between using (1) the in-house cut-off values versus the manufacturer's cut-off values, (2) a normalized ratio calculated using PNP at each run versus the mean of the reference interval, (3) a normalized ratio versus the index of circulating anticoagulant to interpret the mixing step, and (4) a two-step versus three-step procedure. RESULTS: LA testing outcomes were comparable when using the in-house and manufacturer's cut-off values. More positive dilute Russell's viper venom (DRVV) time results were obtained with the normalized ratio based on PNP than with the mean of the reference interval. Overall, the mixing test results obtained with the normalized ratio and the index of circulating anticoagulant showed a good agreement. Among the 97 DRVV Screen test-positive samples, 33 and 89 were classified as LA-positive with the 3-step and the 2-step procedure, respectively. CONCLUSIONS: The cut-off value used and the way to normalize ratios had a limited impact. Conversely, it is important to understand the mixing test characteristics to maximize its diagnostic potential.


Asunto(s)
Síndrome Antifosfolípido , Inhibidor de Coagulación del Lupus , Humanos , Pruebas de Coagulación Sanguínea/métodos , Tiempo de Protrombina , Anticoagulantes/uso terapéutico , Tiempo de Tromboplastina Parcial
2.
Rev Med Interne ; 41(8): 552-558, 2020 Aug.
Artículo en Francés | MEDLINE | ID: mdl-32362366

RESUMEN

INTRODUCTION: Chronic neutrophilic leukemia (CNL) is a rare myeloproliferative syndrome characterized by a significant increase in mature neutrophils. One of the most serious complications is the occurrence of bleeding events, which may sometimes lead to death. CASE REPORT: A 75-year-old patient presented with CNL, complicated by a severe bleeding phenotype. Biological investigations revealed platelet function defect and increase in neutrophil elastase. The follow-up was marked by an intracranial hemorrhage leading to the patient's death 7 months after diagnosis. CONCLUSION: This bleeding phenotype has been reported several times in patients with CNL. However, the pathophysiological mechanisms that cause bleeding are not yet fully understood.


Asunto(s)
Hemorragia Cerebral/etiología , Leucemia Neutrofílica Crónica/complicaciones , Anciano , Hemorragia Cerebral/diagnóstico , Hemorragia Cerebral/patología , Resultado Fatal , Humanos , Leucemia Neutrofílica Crónica/diagnóstico , Leucemia Neutrofílica Crónica/patología , Masculino , Agregación Plaquetaria
4.
Rev Med Interne ; 21(10): 837-43, 2000 Oct.
Artículo en Francés | MEDLINE | ID: mdl-11075392

RESUMEN

OBJECTIVE: This study was aimed at determining the diagnostic value of conventional laboratory tests regarding the iron status and serum transferrin receptor in hospitalized patients. METHODS: Patients who had to undergo bone marrow aspirate examination were included in this 8-month prospective study. Iron deficiency was defined as the absence of stainable iron on bone marrow examination. Patients with stainable iron were included in the control group. The higher value of diagnostic efficacy determined the cut-off value for each parameter of the iron status. RESULTS: Twenty-one patients (17 females, four males) (mean age: 52 years) with iron deficiency and 33 control subjects (20 females, 13 males) (mean age: 60 years) were included in the study. The ratio serum transferrin receptor/serum ferritin had the best diagnostic efficiency (78%) with a sensitivity of 81% and a specificity of 97%. Serum ferritin alone with a cut-off value of 60 micrograms/L had the same specificity (97%) but a lower sensitivity (76%). The diagnostic value of all other analyzed tests was below 66% (transferrin alone, mean corpuscular volume, transferrin saturation, iron, serum transferrin receptor alone, red cell distribution width). CONCLUSION: Among in-patients, ferritin remains the first intention test to diagnose iron deficiency, but the cut-off value should be increased (60 micrograms/L in this study). The ratio "serum transferrin receptor to serum ferritin" provides the highest specificity with a higher cost and should be used only in doubtful cases.


Asunto(s)
Anemia Ferropénica/sangre , Anemia Ferropénica/diagnóstico , Ferritinas/sangre , Receptores de Transferrina/sangre , Anemia Ferropénica/patología , Examen de la Médula Ósea , Estudios de Casos y Controles , Costos y Análisis de Costo , Índices de Eritrocitos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Sensibilidad y Especificidad , Albúmina Sérica/análisis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...